Off-Label Use of Atypical AntipsychoticsCause for Concern?

被引：0
|
作者：
Andrew McKean
Erik Monasterio
机构：
[1] The Princess Margaret Hospital,Pharmacy Department
[2] Hillmorton Hospital,Medlicott Academic Unit
来源：
CNS Drugs | 2012年 / 26卷
关键词：
Major Depressive Disorder; Anxiety Disorder; Risperidone; Olanzapine; Quetiapine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Licensed indications for medicines were designed to regulate the claims that can be made about a medicine by a pharmaceutical company. Off-label prescribing (i.e. prescribing a drug for an indication outside of that for which it is licensed) is legal and an integral part of medical practice. In psychiatry, off-label prescribing is common and gives clinicians scope to treat patients who are refractory to standard therapy or where there is no licensed medication for an indication. However, efficacy or safety of such off-label use may not be established.
引用
收藏
页码：383 / 390
页数：7
相关论文
共 50 条
  • [41] Off-label use of atypical antipsychotics among patients with bipolar disorder in medicaid
    Jing, Yonghua
    Keck, Paul E.
    Guo, Jeff J.
    Li, Hong
    Li, Xing
    Patel, Nick C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S221 - S221
  • [42] Off-label use of atypical antipsychotics in the crisis intervention unit: An observational study
    Sarotar, B. Novak
    Segrec, N.
    EUROPEAN PSYCHIATRY, 2008, 23 : S166 - S166
  • [43] Off-label use in psychopharmacotherapy [Off-Label-Use in der Psychopharmakotherapie]
    Fritze J.
    Schmauss M.
    Der Nervenarzt, 2002, 73 (8) : 796 - 799
  • [44] Use Pattern and Off-Label Use of Atypical Antipsychotics in Bipolar Disorder, 1998-2002
    Demland, Jeffery A.
    Jing, Yonghua
    Kelton, Christina M. L.
    Guo, Jeff J.
    Li, Hong
    Wigle, Patricia R.
    AMERICAN HEALTH AND DRUG BENEFITS, 2009, 2 (04): : 184 - 191
  • [45] Off-Label indications for atypical antipsychotics: a systematic review
    KN Fountoulakis
    I Nimatoudis
    A Iacovides
    G Kaprinis
    Annals of General Hospital Psychiatry, 2 (Suppl 1):
  • [46] Atypical antipsychotic agents: Are off-label uses effective?
    不详
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2007, 45 (03) : 10 - 10
  • [47] Off-label indications for atypical antipsychotics: A systematic review
    Fountoulakis K.N.
    Nimatoudis I.
    Iacovides A.
    Kaprinis G.
    Annals of General Hospital Psychiatry, 3 (1):
  • [48] Off-label indications for atypical antipsychotics: A systematic review
    Fountoulakis, K
    Nimatoudis, I
    Iacovides
    Kaprinis, S
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S281 - S281
  • [49] Off-Label Use vs Off-Label Marketing Part 2: Off-Label Marketing- Consequences for Patients, Clinicians, and Researchers
    Van Norman, Gail A.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2023, 8 (03): : 359 - 370
  • [50] Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics
    Christian Lenk
    Philipp Koch
    Hildegard Zappel
    Claudia Wiesemann
    European Journal of Pediatrics, 2009, 168 : 1473 - 1478
12345